Microbot Medical, Inc. Common Stock

MBOT

Microbot Medical, Inc. is a medical device company focused on developing innovative robotic and microservice solutions for minimally invasive procedures. The company’s technology aims to improve patient outcomes by enabling enhanced precision, safety, and ease of use in various interventional healthcare applications.

$1.99 -0.03 (-1.73%)
🚫 Microbot Medical, Inc. Common Stock does not pay dividends

Company News

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
GlobeNewswire Inc. • Microbot Medical Inc. • October 7, 2025

Microbot Medical completed a three-tranche preferred investment option exercise, raising approximately $29.2 million in gross proceeds, with potential additional proceeds of $63 million from future option exercises.

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
GlobeNewswire Inc. • Microbot Medical Inc. • September 16, 2025

Microbot Medical raised $25.2 million in the first closing of a preferred investment option exercise, with potential additional gross proceeds of up to $92.2 million. The company plans to use the funds for developing its LIBERTY Robotic System, potential acquisitions, and general corporate purposes.

Microbot Medical Closes $13 Million Registered Direct Offering
GlobeNewswire Inc. • Microbot Medical Inc. • February 11, 2025

Microbot Medical Inc. announced the closing of a registered direct offering and concurrent private placement, raising approximately $13 million. The company plans to use the proceeds for the development, commercialization, and regulatory activities of its LIBERTY® Robotic System, as well as for working capital and other general corporate purposes.

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial - GlobeNewswire
GlobeNewswire Inc. • N/A • July 9, 2024

Baptist Hospital of Miami has completed its first clinical procedure using Microbot Medical's LIBERTY® Endovascular Robotic Surgical System, which is part of the company's pivotal human clinical trial. This is the second site to perform clinical procedures for the trial, which aims to support the future submission to the FDA for the commercializ...

Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY - Zacks Investment Research
Zacks Investment Research • Zacks Equity Research • July 4, 2024

Microbot Medical has signed a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System. The trial has received Institutional Review Board approval, and the Baptist Hospital is the second site to participate in the clinical trial. The market for robotic-assisted endovascular systems is expect...

Related Companies